Bio-Rad Laboratories (BIO) Shares Outstanding (2010 - 2026)

Bio-Rad Laboratories (BIO) has 17 years of Shares Outstanding data on file, last reported at $5.1 million in Q1 2026.

• Quarterly Shares Outstanding fell 77.55% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 77.55% YoY) and the FY2025 annual result came in at $5.1 million, down 79.89% from the prior year.
• Shares Outstanding was little changed at $5.1 million in Q1 2026 per BIO's latest filing, from $5.1 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $25.2 million in Q1 2026 and bottomed at $5.1 million in Q2 2022.
• The 5-year median for Shares Outstanding is $5.1 million (2023), against an average of $14.1 million.
• Peak annual rise in Shares Outstanding reached 396.48% in 2025, while the deepest fall reached 79.89% in 2025.
• Tracing BIO's Shares Outstanding over 5 years: stood at $5.1 million in 2022, then grew by 0.43% to $5.1 million in 2023, then surged by 394.34% to $25.2 million in 2024, then sank by 79.89% to $5.1 million in 2025, then slipped by 0.0% to $5.1 million in 2026.
• Per Business Quant, the three latest BIO Shares Outstanding figures stand at $5.1 million (Q1 2026), $5.1 million (Q4 2025), and $25.2 million (Q3 2025).

Peer Comparison